Regulation 17 Neuromuscular blocking agents

For section 17 substitute—

“Neuromuscular blocking agents

17

(1)

A person must not use a neuromuscular blocking agent in the course of a regulated procedure unless—

(a)

the person is expressly authorised to do so by the personal licence and the project licence under which the procedure is carried out; and

(b)

the agent is used in combination with such level of anaesthesia or analgesia as is determined in accordance with the project licence.

(2)

The Secretary of State must not grant a project licence that authorises the use of a neuromuscular blocking agent unless the Secretary of State is satisfied, on the basis of a scientific justification, that the purposes of the programme of work specified in the licence cannot be achieved without the use of such an agent.”